Biotechnology

Sterne Kessler is a pioneer in the protection and enforcement of biotechnology IP, including biopharmaceuticals, industrial biotechnology, and biosimilars.

Sterne Kessler’s biotechnology practice was established just as the biotech revolution was beginning. Today, our practice is as diverse as the industry itself. We counsel clients worldwide on IP strategy across major applications of biotechnology—medicine and healthcare, agricultural processes, non-food and industrial processes, and environmental uses. Clients trust Sterne Kessler throughout the product lifecycle to help them navigate the opportunities and challenges unique to the industry.

  • Biopharmaceuticals
    Sterne Kessler’s biopharmaceuticals team works with biologic drug companies to develop, enforce, and defend patent portfolios.
  • Biosimilars
    We help companies navigate the substantial opportunities and challenges associated with the launch of new biosimilar drugs.
  • Therapeutic Antibodies
    We carefully manage intellectual property (IP) issues for therapeutic antibody innovators, ensuring they navigate development hurdles and achieve ambitious financial objectives.
  • Industrial & Agricultural Biotech
    Sterne Kessler has developed landmark patents and won seminar disputes in the industrial and agricultural biotechnology industry.

Leadership

Speaking Engagement

November 3, 2026 12:00 AM – 12:00 AM PST

LSPN North America Fall 2026

Speaking Engagement

November 1, 2026 12:00 AM – 12:00 AM PST

6th Annual AFCC Global Biobased Economy Conference

Industry Event

October 23, 2026 12:00 AM – 12:00 AM PST

Bio Innovation Conference

Articles

October 22, 2026

Will Washington Regulate Biotech Licensing Like Semiconductors? Tracking BINSA and Treasury’s Next Move

Sterne, Kessler, Goldstein & Fox

Firm News

October 21, 2026

Sterne Kessler Secures Second PTAB Win in Challenge to University of Washington Patent

Sterne, Kessler, Goldstein & Fox

Articles

October 15, 2026

When the Window Closes: The New Timing of Patent Value in Life Sciences

Managing IP